EDGAR Filing Documents for 0001104659-16-125231

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-16-125231

Filing Date

2016-06-03

Accepted

2016-06-03 07:29:36

Documents

Period of Report

2016-06-02

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a16-12745_16k.htm	6-K	15770
2	EX-99.1	a16-12745_1ex99d1.htm	EX-99.1	6169
3	GRAPHIC	g127451mmi001.jpg	GRAPHIC	3085
	Complete submission text file	0001104659-16-125231.txt		27397

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 161694190
SIC: 2834 Pharmaceutical Preparations